blue 3D waveform render

Investors

Welcome to the iCAD Investors page.

iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes. Headquartered in Nashua, N.H., iCAD’s industry-leading ProFound Breast Health Suite provides AI-powered mammography analysis for breast cancer detection, density assessment and risk evaluation. Used by thousands of providers serving millions of patients, ProFound is available in over 50 countries. In the last five years alone, iCAD estimates reading more than 40 million mammograms worldwide, with nearly 30% being tomosynthesis. For more information, including the latest in regulatory clearances, please visit www.icadmed.com

2024 Investor Deck

Sign up to receive Investor Alerts.

Subscribe to receive investor alerts from iCAD, Inc.

Press Releases

May 15, 2024

iCAD Reports Financial Results for First Quarter Ended March 31, 2024

NASHUA, N.H. – May 15, 2024 – iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2024. First Quarter…

May 2, 2024

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

UPDATE: Call Time is 8:30 AM Eastern Time NASHUA, N.H., May 2, 2024 — iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first quarter ended March 31, 2024, pre-market and host a conference call at…

April 11, 2024

iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium

NASHUA, N.H., April 11, 2024 — iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will showcase its ProFound Breast Health Suite of AI solutions, including the newly released ProFound Cloud, powered by Google Cloud and Google Health AI architecture, while also…

Recent Events & Earning Calls

009 – Graph Created with Sketch.

Investor Relations

iCAD Investor Relations
ir@icadmed.com
Megaphone

Media Inquiries